Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

NPHCNUTRA PHARMA CORP

OTC · CIK 0001119643
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2833 Medicinal Chemicals & Botanical Products
FY end1231
XBRL facts534

Identity from submissions API

NameNUTRA PHARMA CORP
CIK0001119643
TickersNPHC
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2833 Medicinal Chemicals & Botanical Products
EIN912021600
LEI—
Fiscal year end1231
State of incorporationCA CA
Phone(954) 509-0911
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • CYBER VITAMIN COM (2000-10-03T04:00:00.000Z → 2002-02-28T05:00:00.000Z)
Business address
6400 PARK OF COMMERCE BLVD
SUITE 1B
BOCA RATON
FL
33487
FL
Mailing address
6400 PARK OF COMMERCE BLVD
SUITE 1B
BOCA RATON
FL
33487
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

350 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 NT 10-Q NT 10-Q 0001493152-26-052272 000-32141 261559700 34 27816
2026-09-02 8-K 8-K 5.01 0001493152-26-041208 000-32141 261354127 34 198949 1 1
2026-09-01 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001493152-26-041007 005-62377 261350540 34 8469
2026-09-01 3 3 0001493152-26-041005 3986
2026-09-01 4 4 0001493152-26-041002 5291
2026-08-19 10-Q 10-Q 0001493152-26-039166 000-32141 261294255 34 9223550 1 1
2026-08-14 NT 10-Q NT 10-Q 0001493152-26-038022 000-32141 261276538 34 27541
2026-05-29 10-Q 10-Q 0001493152-26-026420 000-32141 261045793 34 9114978 1 1
2026-05-20 10-K 10-K 0001493152-26-024641 000-32141 261004785 34 10412268 1 1
2026-04-06 10-Q 10-Q 0001493152-26-015334 000-32141 26842088 34 9406375 1 1
2026-03-25 10-Q 10-Q 0001493152-26-012625 000-32141 26791308 34 9535858 1 1
2026-03-11 10-Q 10-Q 0001493152-26-009667 000-32141 26743006 34 8694843 1 1
2026-02-17 10-K 10-K 0001493152-26-007044 000-32141 26639572 34 11243914 1 1
2026-01-02 10-Q 10-Q 0001493152-26-000067 000-32141 26501687 34 9686207 1 1
2025-12-23 10-Q 10-Q 0001493152-25-028946 000-32141 251597750 34 9900171 1 1
2025-12-17 10-Q 10-Q 0001493152-25-028202 000-32141 251580109 34 9648647 1 1
2025-11-24 10-K 10-K 0001493152-25-024800 000-32141 251511765 34 12832963 1 1
2025-10-28 10-Q 10-Q 0001493152-25-019875 000-32141 251424738 34 11678171 1 1
2025-10-23 10-Q 10-Q 0001493152-25-019037 000-32141 251412423 34 11018659 1 1
2025-10-16 10-Q 10-Q 0001493152-25-018328 000-32141 251398076 34 10520662 1 1
2025-09-03 10-K 10-K 0001641172-25-026446 000-32141 251291162 34 12578371 1 1
2025-09-03 8-K 8-K 4.01,9.01 0001641172-25-026384 000-32141 251289409 34 216093 1 1
2024-03-22 8-K form8-k.htm 5.02,7.01,8.01,9.01 0001493152-24-010998 000-32141 24775829 34 263857 1 1
2022-11-21 10-Q form10-q.htm 0001493152-22-033171 000-32141 221406817 34 9511744 1 1
2022-11-15 NT 10-Q formnt10-q.htm 0001493152-22-032495 000-32141 221391185 34 27574
2022-08-22 10-Q form10-q.htm 0001493152-22-023751 000-32141 221184372 34 9292181 1 1
2022-08-15 NT 10-Q formnt10-q.htm 0001493152-22-022953 000-32141 221166542 34 27122
2022-08-04 8-K form8-k.htm 4.01,9.01 0001493152-22-021351 000-32141 221137342 34 421244 1 1
2022-05-20 10-Q form10-q.htm 0001493152-22-014637 000-32141 22948445 34 8433728 1 1
2022-05-16 NT 10-Q formnt10-q.htm 0001493152-22-013761 000-32141 22928782 34 27515
2022-04-15 10-K form10-k.htm 0001493152-22-010035 000-32141 22829456 34 10164799 1 1
2022-04-01 NT 10-K formnt10k.htm 0001493152-22-008863 000-32141 22799113 34 26351
2022-03-24 DEF 14C formdef14c.htm 0001493152-22-007568 000-32141 22764112 34 181241
2022-01-14 5 xslF345X03/ownership.xml 0001493152-22-001313 7750
2022-01-14 SC 13D/A formsc13da.htm 0001493152-22-001307 005-62377 22532664 34 63473
2022-01-14 PRE 14C formpre14-c.htm 0001493152-22-001304 000-32141 22532643 34 179646
2021-11-10 10-Q form10-q.htm 0001493152-21-027793 000-32141 211395520 34 9884359 1 1
2021-09-24 10-Q form10-q.htm 0001493152-21-023540 000-32141 211275537 34 10317475 1 1
2021-09-17 10-Q form10-q.htm 0001493152-21-022993 000-32141 211260226 34 6665250 1
2021-09-08 10-K form10-k.htm 0001493152-21-022204 000-32141 211242212 34 8660334 1
2021-08-12 10-Q form10-q.htm 0001493152-21-019469 000-32141 211167000 34 8264923 1
2021-08-05 10-Q form10-q.htm 0001493152-21-018715 000-32141 211147945 34 8282561 1
2021-07-23 10-Q form10-q.htm 0001493152-21-017638 000-32141 211111213 34 7815243 1
2021-07-01 10-K form10-k.htm 0001493152-21-015860 000-32141 211066678 34 10413476 1
2021-05-14 10-Q form10-q.htm 0001493152-21-011455 000-32141 21923583 34 6841500 1
2021-05-07 10-Q FORM 10-Q 0001398432-21-000040 000-32141 21900548 34 7298501 1
2021-04-05 10-Q a14262.htm 0001398432-21-000029 000-32141 21805034 34 6602032 1
2021-02-05 10-K a14261.htm 0001398432-21-000007 000-32141 21596991 34 8952690 1
2019-04-01 NT 10-K i14197.htm 0001398432-19-000034 000-32141 19720628 34 13467
2018-11-19 10-Q FORM 10-Q 0001398432-18-000131 000-32141 181192588 34 4976744 1
2018-11-14 NT 10-Q FORM NT 10-Q 0001398432-18-000129 000-32141 181183923 34 13505
2018-10-09 8-K FORM 8-K 4.01,9.01 0001398432-18-000113 000-32141 181114433 34 475454
2018-09-28 8-K FORM 8-K 7.01,8.01,9.01 0001398432-18-000109 000-32141 181095092 34 59385
2018-08-17 10-Q FORM 10-Q 0001398432-18-000103 000-32141 181025829 34 4444698 1
2018-08-14 NT 10-Q FORM NT 10-Q 0001398432-18-000097 000-32141 181017299 34 13500
2018-06-29 SC 13D SCHEDULE 13D 0001398432-18-000089 005-62377 18929624 34 26118
2018-06-26 4 OWNERSHIP DOCUMENT 0001387131-18-002844 14680
2018-06-06 SC 13D SCHEDULE 13D 0001398432-18-000082 005-62377 18884114 34 26468
2018-05-21 10-Q FORM 10-Q 0001398432-18-000069 000-32141 18849847 34 4122908 1
2018-05-15 NT 10-Q FORM NT 10-Q 0001398432-18-000064 000-32141 18836463 34 13495
2018-04-17 10-K FORM 10-K 0001398432-18-000049 000-32141 18758805 34 7221645 1
2018-04-02 NT 10-K i14124.htm 0001398432-18-000044 000-32141 18729647 34 13467
2018-03-20 DEF 14C a14120.htm 0001398432-18-000042 000-32141 18702248 34 53790
2018-03-08 PRE 14C a14120.htm 0001398432-18-000035 000-32141 18676739 34 53382
2018-03-07 8-K a14118.htm 5.02 0001398432-18-000030 000-32141 18673470 34 10803
2018-02-05 SC 13G/A AMENDMENT TO FORM SC 13G 0001213900-18-001292 005-62377 18573334 34 48240
2018-02-02 SC 13G SCHEDULE13G 0001213900-18-001174 005-62377 18568380 34 48213
2017-11-20 10-Q FORM 10-Q 0001398432-17-000163 000-32141 171213805 34 5835689 1
2017-11-14 NT 10-Q FORM NT 10-Q 0001398432-17-000161 000-32141 171201631 34 13505
2017-11-03 8-K FORM 8-K 3.02,5.01,5.03,9.01 0001398432-17-000152 000-32141 171176419 34 25316
2017-08-14 10-Q FORM 10-Q 0001398432-17-000126 000-32141 171029094 34 5139951 1
2017-05-17 10-Q FORM 10-Q 0001398432-17-000086 000-32141 17852547 34 4350907 1
2017-05-17 3 OWNERSHIP DOCUMENT 0001387131-17-002863 5260
2017-05-15 NT 10-Q FORM NT 10-Q 0001398432-17-000082 000-32141 17845828 34 13495
2017-05-04 8-K FORM 8-K 4.01 0001398432-17-000077 000-32141 17814987 34 74309
2017-04-17 10-K FORM 10-K 0001398432-17-000073 000-32141 17764557 34 9788207 1
2017-03-31 NT 10-K i13072.htm 0001398432-17-000061 000-32141 17729598 34 13468
2016-11-22 10-Q FORM 10-Q 0001398432-16-000772 000-32141 162012900 34 6978834 1
2016-11-15 NT 10-Q FORM NT 10-Q 0001398432-16-000766 000-32141 161999780 34 13506
2016-08-22 10-Q a12892.htm 0001398432-16-000724 000-32141 161845405 34 5842985 1
2016-08-15 NT 10-Q FORM NT 10-Q 0001398432-16-000713 000-32141 161832536 34 13498
2016-07-27 8-K FORM 8-K 5.02 0001398432-16-000687 000-32141 161785221 34 18099
2016-06-21 10-Q/A FORM 10-Q AMENDMENT NO. 1 0001398432-16-000672 000-32141 161723412 34 2611088 1
2016-05-27 10-Q a12856.htm 0001398432-16-000665 000-32141 161682808 34 353039
2016-05-17 NT 10-Q FORM NT 10-Q 0001398432-16-000655 000-32141 161658321 34 13481
2016-04-14 10-K a12923.htm 0001398432-16-000597 000-32141 161570607 34 3782095 1
2016-03-30 NT 10-K i12904.htm 0001398432-16-000554 000-32141 161539632 34 13469
2015-11-23 10-Q a12835.htm 0001398432-15-000411 000-32141 151248577 34 2765907 1
2015-11-17 NT 10-Q i12833.htm 0001398432-15-000406 000-32141 151238229 34 17015
2015-08-18 10-Q i12803.htm 0001398432-15-000317 000-32141 151062001 34 2675068 1
2015-08-17 NT 10-Q i12801.htm 0001398432-15-000311 000-32141 151058115 34 15635
2015-05-19 10-Q i12773.htm 0001398432-15-000257 000-32141 15876018 34 3076776 1
2015-05-18 NT 10-Q i12775.htm 0001398432-15-000253 000-32141 15872350 34 15632
2015-04-29 8-K a12743.htm 3.03,5.03,9.01 0001398432-15-000195 000-32141 15812342 34 25058
2015-04-21 8-K a12736.htm 5.07 0001398432-15-000180 000-32141 15782821 34 13699
2015-04-13 10-K a12728.htm 0001398432-15-000168 000-32141 15766941 34 4983718 1
2015-04-01 NT 10-K i12720.htm 0001398432-15-000141 000-32141 15741377 34 13441
2015-03-17 DEF 14A a12696.htm 0001398432-15-000101 000-32141 15705449 34 81966
2015-03-03 PRE 14A a12696.htm 0001398432-15-000085 000-32141 15670074 34 81995
2014-11-14 10-Q i12650.htm 0001398432-14-000409 000-32141 141224057 34 2958819 1
2014-08-18 10-Q/A i12611.htm 0001398432-14-000325 000-32141 141049278 34 699720
2014-08-14 10-Q nutra_10q.htm 0001398432-14-000313 000-32141 141043682 34 2918538 1
2014-05-20 10-Q fwdnutrapharmas10q.htm 0001552781-14-000479 000-32141 14857882 34 3120015 1
2014-05-16 NT 10-Q i12567.htm 0001398432-14-000209 000-32141 14850635 34 15456
2014-03-31 10-K ANNUAL REPORT 0001144204-14-019555 000-32141 14731006 34 8986964 1
2014-03-28 4 FORM 4 0001144204-14-018923 6134
2014-03-25 4 OWNERSHIP DOCUMENT 0001144204-14-017709 7418
2014-03-21 4 OWNERSHIP DOCUMENT 0001144204-14-017035 10435
2014-03-21 4 OWNERSHIP DOCUMENT 0001144204-14-017004 11915
2013-11-19 10-Q FORM 10-Q 0001144204-13-063102 000-32141 131230595 34 6463856 1
2013-11-18 NTN 10Q NOTIFICATION OF LATE FILING 0001144204-13-062668 000-32141 131226097 34 21031
2013-09-25 8-K FORM 8-K 8.01,9.01 0001144204-13-052238 000-32141 131113348 34 53660
2013-08-19 10-Q FORM V352627 0001144204-13-046848 000-32141 131048346 34 8130860 1
2013-08-15 NT 10-Q FORM 12B-25 0001144204-13-046336 000-32141 131042555 34 18597
2013-05-20 10-Q FORM 10-Q 0001144204-13-030545 000-32141 13858730 34 4488589 1
2013-05-15 NT 10-Q FORM 12B-25 0001144204-13-029610 000-32141 13847950 34 20072
2013-04-16 10-K FORM 10-K 0001144204-13-022247 000-32141 13764756 34 7207410 1
2013-04-01 NT 10-K NT 10-K 0001144204-13-019095 000-32141 13730986 34 22412
2013-03-28 4 OWNERSHIP DOCUMENT 0001144204-13-018044 4661
2012-12-14 8-K CURRENT REPORT 4.01,9.01 0001144204-12-068059 000-32141 121266438 34 195512
2012-12-12 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001144204-12-067558 000-32141 121258469 34 4199948 1
2012-12-07 10-Q/A AMENDMENT TO FORM 10-Q 0001144204-12-066928 000-32141 121249693 34 4124738 1
2012-12-05 10-Q QUARTERLY REPORT 0001144204-12-066556 000-32141 121243703 34 388265
2012-12-03 10-Q QUARTERLY REPORT 0001144204-12-066091 000-32141 121237932 34 389788
2012-11-28 10-Q/A AMENDMENT TO FORM 10-Q 0001144204-12-065280 000-32141 121228933 34 1379025 1
2012-11-21 10-Q FORM 10-Q 0001144204-12-064585 000-32141 121221810 34 416098
2012-11-15 10-K/A AMENDMENT TO FORM 10-K 0001144204-12-063254 000-32141 121209293 34 2677945 1
2012-11-13 10-K FORM 10-K 0001144204-12-061035 000-32141 121195062 34 790164
2012-09-12 8-K FORM 8-K 5.02 0001144204-12-050877 000-32141 121087806 34 10837
2012-09-11 4 OWNERSHIP DOCUMENT 0001144204-12-050640 17796
2012-09-07 4 OWNERSHIP DOCUMENT 0001144204-12-050069 4462
2012-04-26 4 OWNERSHIP DOCUMENT 0001144204-12-024115 4498
2012-04-19 4 OWNERSHIP DOCUMENT 0001144204-12-022609 4692
2012-04-17 4 OWNERSHIP DOCUMENT 0001144204-12-022335 4701
2012-04-02 NT 10-K NT 10-K 0001144204-12-019443 000-32141 12733338 34 7648
2012-03-19 8-K FORM 8-K 1.01,3.02,9.01 0001144204-12-015858 000-32141 12700838 34 3049930
2012-03-09 8-K FORM 8-K 5.02 0001144204-12-013878 000-32141 12678800 34 14336
2011-11-15 10-Q QUARTERLY REPORT 0001144204-11-064907 000-32141 111206263 34 1664297 1
2011-11-15 NT 10-Q NOTIFICATION OF LATE FILING FOR FORM 10-Q 0001144204-11-064767 000-32141 111205504 34 25967
2011-08-15 10-Q QUARTERLY REPORT 0001144204-11-047222 000-32141 111036457 34 1501192 1
2011-05-16 10-Q QUARTERLY REPORT 0001144204-11-029878 000-32141 11846112 34 506648
2011-04-01 10-K v217084_10k.htm 0001144204-11-019488 000-32141 11729432 34 1069568
2011-04-01 NT 10-K v217188_nt10k.txt 0001144204-11-019384 000-32141 11728618 34 6645
2011-03-30 4 xslF345X03/v216556_ex.xml 0001144204-11-018090 5595
2011-01-07 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2011-01-07 15:00:00 9999999995-11-000093 333-171147 11518731 33 2164
2011-01-06 S-1/A v207475_s1-a.htm 0001144204-11-000982 333-171147 11513560 33 1635921
2011-01-05 10-Q/A v207226_10q-a.htm 0001144204-11-000684 000-32141 11509630 34 500926
2011-01-05 10-Q/A v207234_10q-a.htm 0001144204-11-000682 000-32141 11509620 34 430979
2011-01-05 10-Q/A v207231_10q-a.htm 0001144204-11-000679 000-32141 11509610 34 383801
2010-12-21 5 xslF345X03/v206266_ex.xml 0001144204-10-067682 6148
2010-12-21 8-K v206170_8k.htm 5.02 0001144204-10-067500 000-32141 101264358 34 15761
2010-12-14 S-1 v205282_s1.htm 0001144204-10-066351 333-171147 101250278 33 1632964
2010-11-15 10-Q v202385_10q.htm 0001144204-10-060384 000-32141 101190283 34 500798
2010-11-12 8-K v201981_8-k.htm 1.01,3.02,9.01 0001144204-10-059610 000-32141 101185194 34 524346
2010-08-18 8-K v194562_8-k.htm 5.02 0001144204-10-045386 000-32141 101025708 34 15214
2010-08-16 10-Q v193546_10q.htm 0001144204-10-044382 000-32141 101018779 34 430528
2010-08-06 8-K v192764_8k.htm 2.02,9.01 0001144204-10-041849 000-32141 10997630 34 88539
2010-06-24 UPLOAD filename1.pdf 0000000000-10-035656 11885
2010-05-21 10-Q v186123_10q.htm 0001144204-10-029612 000-32141 10851115 34 383396
2010-05-18 NT 10-Q v185529_nt-10q.htm 0001144204-10-028679 000-32141 10841274 34 28842
2010-04-15 10-K v181067_10k.htm 0001144204-10-020406 000-32141 10751667 34 1096293
2010-04-09 4 xslF345X03/v179658_ex.xml 0001144204-10-019352 4834
2010-04-09 4 PRIMARY DOCUMENT 0001322956-10-000001 3377
2010-04-08 CORRESP filename1.htm 0001144204-10-019091 24227
2010-04-08 10-K/A v179724_10ka.htm 0001144204-10-019089 000-32141 10739297 34 1622283
2010-04-05 3/A PRIMARY DOCUMENT 0001476235-10-000005 4130
2010-04-05 3 xslF345X02/v179671_ex.xml 0001144204-10-018454 3835
2010-04-01 NT 10-K v179731_nt10k.txt 0001144204-10-017907 000-32141 10722940 34 7118
2010-03-22 UPLOAD filename1.pdf 0000000000-10-015681 45927
2010-02-17 4 PRIMARY DOCUMENT 0001476235-10-000004 4811
2010-02-17 4 PRIMARY DOCUMENT 0001476235-10-000003 4810
2010-02-11 3 xslF345X02/v173974_ex.xml 0001144204-10-006642 4979
2010-02-05 4 PRIMARY DOCUMENT 0001476235-10-000002 4810
2010-02-05 4 PRIMARY DOCUMENT 0001476235-10-000001 4810
2010-02-02 8-K CURRENT REPORT 2.02,9.01 0001144204-10-004796 000-32141 10565035 34 76412
2010-01-25 CORRESP filename1.htm 0001144204-10-003339 53306
2010-01-25 10-Q/A v171819_10qa.htm 0001144204-10-003337 000-32141 10543996 34 663551
2010-01-25 10-K/A v171818_10ka.htm 0001144204-10-003335 000-32141 10543990 34 1621888
2010-01-21 3 xslF345X02/v171944_ex.xml 0001144204-10-002915 4427
2010-01-13 CORRESP filename1.htm 0001144204-10-001785 26706
2010-01-13 4 xslF345X03/v171299_ex.xml 0001144204-10-001777 4679
2010-01-13 3 xslF345X02/v171298_ex.xml 0001144204-10-001775 3875
2009-12-31 8-K/A v170292_8k-a.htm 4.01 0001144204-09-066997 000-32141 091267811 34 14572
2009-12-24 8-K v169968_8-k.htm 4.01,9.01 0001144204-09-066351 000-32141 091260278 34 60670
2009-12-16 CORRESP filename1.htm 0001144204-09-064933 9148
2009-12-15 UPLOAD filename1.pdf 0000000000-09-070689 67611
2009-11-18 10-Q v166879_10q.htm 0001144204-09-060692 000-32141 091193631 34 546109
2009-11-18 8-K/A v166883_8-ka.htm 9.01 0001144204-09-060684 000-32141 091193581 34 698197
2009-11-17 NT 10-Q v166767_nt10q.htm 0001144204-09-060190 000-32141 091188897 34 29055
2009-11-12 4 PRIMARY DOCUMENT 0001322956-09-000002 3445
2009-11-10 4 PRIMARY DOCUMENT 0001322956-09-000001 4834
2009-11-05 3 PRIMARY DOCUMENT 0001476235-09-000001 3904
2009-10-06 8-K v162178_8-k.htm 3.02 0001144204-09-051735 000-32141 091108212 34 25505
2009-08-19 10-Q v158492_10q.htm 0001144204-09-044591 000-32141 091023731 34 690825
2009-08-17 NT 10-Q v158276_nt10q.txt 0001144204-09-044000 000-32141 091018177 34 6886
2009-07-29 8-K v155835_8-k.htm 5.02,9.01 0001144204-09-039311 000-32141 09970845 34 32299
2009-05-20 10-Q v150209_10q.htm 0001144204-09-028468 000-32141 09841615 34 758797
2009-05-15 NT 10-Q v149970_nt10q.txt 0001144204-09-027487 000-32141 09833018 34 7139
2009-04-15 10-K v146185_10k.htm 0001144204-09-020656 000-32141 09750763 34 1573438
2009-04-01 NT 10-K v145035_nt10k.txt 0001144204-09-018189 000-32141 09721787 34 7151
2008-11-19 10-Q v132750_10q.htm 0001144204-08-065401 000-32141 081200144 34 576717
2008-11-17 NT 10-Q v132579_nt10q.txt 0001144204-08-064790 000-32141 081194438 34 7246
2008-10-07 UPLOAD filename1.pdf 0000000000-08-050514 15547
2008-10-07 UPLOAD filename1.pdf 0000000000-08-050512 21297
2008-10-03 10KSB/A v127907_10ksb-a.htm 0001144204-08-055902 000-32141 081105236 34 111957
2008-09-25 CORRESP filename1.htm 0001144204-08-054500 18327
2008-09-05 10KSB/A v125658_10ksb-a.htm 0001144204-08-051371 000-32141 081057813 34 1334580
2008-08-20 CORRESP filename1.htm 0001144204-08-048841 25674
2008-08-19 10-Q v124103_10q.htm 0001144204-08-048486 000-32141 081027234 34 615324
2008-08-13 NT 10-Q v123185_nt-10q.htm 0001144204-08-046012 000-32141 081011744 34 39212
2008-07-22 UPLOAD filename1.pdf 0000000000-08-036393 34987
2008-05-20 10-Q v115103_10-q.htm 0001144204-08-030933 000-32141 08848039 34 519480
2008-05-16 NT 10-Q v114901_nt10q.htm 0001144204-08-030166 000-32141 08840695 34 31795
2008-04-15 10KSB v110601_10ksb.htm 0001144204-08-022384 000-32141 08756701 34 1312830
2008-04-14 8-K v110538_8k.htm 1.01,2.01,3.02,5.02,9.01 0001144204-08-021933 000-32141 08753566 34 358872
2008-04-14 8-K v110497_8k.htm 5.01 0001144204-08-021922 000-32141 08753526 34 65493
2008-04-08 8-K/A v109912_8ka.htm 3.02 0001144204-08-021072 000-32141 08744549 34 35432
2008-04-07 8-K/A v109912_8ka.htm 3.02 0001144204-08-020915 000-32141 08742332 34 35471
2008-04-01 4 xslF345X02/v108351_ex.xml 0001144204-08-019849 6037
2008-04-01 SC 13D v108349_sc13d.txt 0001144204-08-019847 005-62377 08729341 34 10809
2008-04-01 NT 10-K v109313_nt10k.txt 0001144204-08-019705 000-32141 08728057 34 7047
2008-03-18 8-K v107355_8-k.htm 3.02 0001144204-08-016104 000-32141 08696250 34 29749
2007-11-14 10QSB v094040_10qsb.htm 0001144204-07-061310 000-32141 071244016 34 439666
2007-08-17 10QSB v085197_10qsb.htm 0001144204-07-044759 000-32141 071064224 34 425500
2007-08-15 NT 10-Q v085060_nt10q.txt 0001144204-07-043949 000-32141 071058405 34 6982
2007-06-25 S-8 v078032_s-8.htm 0001144204-07-033335 333-144013 07938289 33 104271
2007-05-21 10QSB v076264_10qsb.htm 0001144204-07-027649 000-32141 07867847 34 434266
2007-05-16 NT 10-Q v075654_nt10q.txt 0001144204-07-026410 000-32141 07856686 34 6769
2007-05-09 8-K v074223_8k.htm 5.02 0001144204-07-023595 000-32141 07831486 34 32585
2007-04-17 10KSB v071687_10ksb.htm 0001144204-07-019180 000-32141 07770640 34 1720484
2007-04-02 NT 10-K v070444_nt10k.txt 0001144204-07-016270 000-32141 07737466 34 7113
2006-11-14 10QSB v057450_10qsb.htm 0001144204-06-047433 000-32141 061214788 34 431509
2006-08-21 10QSB v050741_10qsb.htm 0001144204-06-034864 000-32141 061045413 34 480626
2006-08-15 NT 10-Q v050521_nt10q.txt 0001144204-06-033981 000-32141 061035513 34 8395
2006-05-22 10QSB v044012_10qsb.txt 0001144204-06-021992 000-32141 06858400 34 57799
2006-05-16 NT 10-Q v043506_nt10q.txt 0001144204-06-020985 000-32141 06845072 34 8866
2006-05-02 5 PRIMARY DOCUMENT 0001251265-06-000004 11284
2006-05-02 3 PRIMARY DOCUMENT 0001251265-06-000003 4035
2006-04-28 10KSB v041458_10ksb.htm 0001144204-06-017236 000-32141 06788132 34 1254665
2006-04-07 8-K v040074_8k.htm 1.01,1.02,3.02,5.02,9.01 0001144204-06-014383 000-32141 06747748 34 109449
2006-04-03 NT 10-K v039645_nt10k.txt 0001144204-06-013527 000-32141 06733250 34 8887
2005-11-22 10QSB NUTRA PHARMA CORPORATION - SEPTEMBER 30, 2005 0000950129-05-011327 000-32141 051220950 34 138515
2005-11-15 NT 10-Q NOTIFICATION OF LATE FILING 0001329606-05-000005 000-32141 051206970 34 24134
2005-11-10 8-K FORM 8-K 1.01,3.02 0001329102-05-000006 000-32141 051191459 34 99154
2005-08-23 10QSB NUTRA PHARMA CORP.- JUNE 30, 2005 0000950129-05-008576 000-32141 051043376 34 166102
2005-08-15 NT 10-Q NUTRA PHARMA CORP.- JUNE 30, 2005 0000950129-05-008265 000-32141 051027007 34 20337
2005-06-06 8-K NUTRA PHARMA CORP. 1.01,3.02,5.02,9.01 0000950129-05-005976 000-32141 05881060 34 92536
2005-05-26 10QSB nphc10qsb.htm 0001182063-05-000034 000-32141 05860632 34 58420
2005-05-16 NT 10-Q nphcnt10q0305.htm 0001182063-05-000032 000-32141 05834273 34 8868
2005-05-02 10KSB nphc10k.htm 0001182063-05-000030 000-32141 05791728 34 195978
2005-05-02 4 xslF345X02/flaxform4_ex.xml 0001182063-05-000028 7109
2005-04-29 3 xslF345X02/cherelstein3_ex.xml 0001182063-05-000026 4216
2005-04-26 4 xslF345X02/deitsch4_ex.xml 0001182063-05-000024 5064
2005-04-25 3 xslF345X02/lonky3_ex.xml 0001182063-05-000022 6310
2005-04-25 3 xslF345X02/khandaker3_ex.xml 0001182063-05-000020 4218
2005-04-13 SC 13D opus13dnphc41205.txt 0001086715-05-000022 005-62377 05747058 34 10293
2005-04-12 8-K form8knutrapharma.htm 8.01 0001182063-05-000018 000-32141 05745931 34 4691
2005-03-30 NT 10-K nutrapharmaform12b25.htm 0001182063-05-000016 000-32141 05714466 34 9054
2005-02-24 8-K form8k.htm 4.01,9.01 0001182063-05-000012 000-32141 05637810 34 7825
2005-02-11 10QSB/A amended10qnutraphjune2004.htm 0001182063-05-000010 000-32141 05600053 34 69484
2005-02-11 10QSB/A nutrapharma10qsbamar04.htm 0001182063-05-000008 000-32141 05599929 34 48942
2005-01-20 8-K nutrapharma8k.htm 5.02 0001182063-05-000004 000-32141 05538836 34 4366
2005-01-07 8-K v010931_8k.htm 1.01,9.01 0001144204-05-000638 000-32141 05518691 34 100008
2004-12-21 10QSB nutrapharma10q.htm 0001182063-04-000175 000-32141 041218327 34 178051
2004-11-15 8-K nnphc8k111104.htm 5.02 0001086715-04-000151 000-32141 041144080 34 14218
2004-11-15 NT 10-Q nphc10q093004.txt 0001086715-04-000149 000-32141 041143412 34 9827
2004-10-04 8-K f8k100404x.htm 2.01 0001086715-04-000111 000-32141 041063271 29359
2004-08-27 10QSB nutrapharma10qsb.htm 0001182063-04-000131 000-32141 041002472 64852
2004-08-16 NT 10-Q nutrapharmant10q.htm 0001182063-04-000125 000-32141 04978248 5883
2004-05-26 10QSB MARCH 31, 2004 10Q REPORT 0001086715-04-000065 000-32141 04832041 253410
2004-05-17 NT 10-Q NOTIFICATION OF LATE FILING 0001086715-04-000061 000-32141 04812306 36011
2004-05-07 10KSB/A DECEMBER 31, 2003 10K AMENDMENT 0001086715-04-000057 000-32141 04790258 525722
2004-04-30 5 PRIMARY DOCUMENT 0001086715-04-000056 8470
2004-04-30 5 PRIMARY DOCUMENT 0001086715-04-000055 4961
2004-04-30 5 PRIMARY DOCUMENT 0001086715-04-000054 5078
2004-04-30 4 PRIMARY DOCUMENT 0001086715-04-000053 5099
2004-04-30 5 PRIMARY DOCUMENT 0001086715-04-000052 5109
2004-04-20 10KSB 2003 YEAR END REPORT 0001086715-04-000047 000-32141 04743425 502171
2004-04-08 5 PRIMARY DOCUMENT 0001086715-04-000042 7013
2004-04-08 3 PRIMARY DOCUMENT 0001086715-04-000041 4937
2004-04-08 3 PRIMARY DOCUMENT 0001086715-04-000040 6004
2004-03-30 NT 10-K 10K NOTIFICATION OF LATE FILING 0001086715-04-000032 000-32141 04701529 10018
2004-03-11 8-K CHANGE IN CERTIFYING ACCOUNTANT 4 0001086715-04-000020 000-32141 04663686 4787
2004-03-09 8-K/A CHANGE OF ACCOUNTANT 4 0001086715-04-000018 000-32141 04657340 6652
2004-03-08 8-K ACQUISITION AGREEMENT 2 0001086715-04-000017 000-32141 04655515 33080
2004-02-17 5 PRIMARY DOCUMENT 0001086715-04-000013 5329
2004-02-10 8-K CHANGE IN ACCOUNTANT 4 0001086715-04-000010 000-32141 04580905 5868
2004-01-15 4 PRIMARY DOCUMENT 0001086715-04-000004 5166
2004-01-05 4/A PRIMARY DOCUMENT 0001086715-04-000001 5195
2003-12-22 8-K FORM 8K 5 0001086715-03-000150 000-32141 031067603 13120
2003-12-09 4 PRIMARY DOCUMENT 0001086715-03-000142 5120
2003-12-09 S-8 EMPLOYEE BENEFIT PLAN 0001086715-03-000141 333-111012 031043284 19223
2003-11-19 10QSB SEPTEMBER 30, 2003 QUARTERLY REPORT 0001086715-03-000135 000-32141 031013237 46805
2003-11-14 NT 10-Q NOTIFICATION OF LATE FILING FOR SEPTEMBER 30, 2003 10Q 0001086715-03-000131 000-32141 031005100 9096
2003-11-07 SC 13D/A 57.24% INTEREST IN INFECTECH 0001086715-03-000128 11570
2003-11-06 SC 13D 57.24% OWNERSHIP OF INFECTECH 0001086715-03-000127 11562
2003-10-20 8-K NPHC ACQUISITION OF INFECTECH 2 0001086715-03-000123 000-32141 03946895 52068
2003-10-15 5 PRIMARY DOCUMENT 0001086715-03-000117 5261
2003-10-09 SC 13D/A REGENESIS CAPITAL AMENDMENT SC13D 0001086715-03-000115 005-62377 03935414 10224
2003-10-08 3 PRIMARY DOCUMENT 0001086715-03-000112 3864
2003-10-06 SC 13D/A SCHEDULE 13D AMENDMENT 0001086715-03-000111 005-62377 03929961 9755
2003-10-06 5 PRIMARY DOCUMENT 0001086715-03-000109 4950
2003-10-03 10QSB/A CORRECTED JUNE 30, 2003 10Q 0001086715-03-000108 000-32141 03927484 29135
2003-10-03 SC 13D/A SCHEDULE 13D AMENDMENT 0001086715-03-000106 005-62377 03927063 11855
2003-09-24 10QSB/A JUNE 30, 2003 QUARTERLY REPORT - AMENDMENT 0001086715-03-000105 000-32141 03907675 28261
2003-08-14 10QSB JUNE 2003 0001086715-03-000097 000-32141 03847621 27090
2003-07-24 8-K RETIREMENT OF SHARES OF BIOT AND ISSUANCE TO OPUS 5 0001086715-03-000092 000-32141 03800518 6014
2003-06-19 10QSB/A MARCH 31, 2003 QUARTERLY AMENDED 0001086715-03-000079 000-32141 03750671 29241
2003-05-14 10-Q MARCH 31, 2003 QUARTERLY 0001086715-03-000066 000-32141 03699315 29301
2003-05-02 8-K 8-K 5,6 0001086715-03-000062 000-32141 03680348 6940
2003-04-24 10KSB/A AMENDMENT TO ADD SECTION 302 CERTIFICATIONS ONLY 0001086715-03-000061 000-32141 03661279 87350
2003-04-14 10-K YEAR END REPORT ON FORM 10-K 0001086715-03-000055 000-32141 03648209 81065
2003-03-28 NT 10-K NOTIFICATION OF LATE FILING 2002 10K 0001086715-03-000041 000-32141 03623880 9096
2003-01-06 8-K RESCISSION AGREEMENT DATED 12/26/02 5 0001086715-03-000018 000-32141 03504897 11004
2002-11-14 10-Q 10-QSB 0001086715-02-000091 000-32141 02828792 30406
2002-11-13 NT 10-Q NOTIFICATION OF LATE FILING 0001086715-02-000086 000-32141 02819017 9072
2002-11-05 8-K/A 3RD AMENDMENT 2 0001168460-02-000055 000-32141 02808993 79514
2002-10-31 8-K/A 8K 6 0001168460-02-000053 000-32141 02805171 5019
2002-10-31 8-K/A 8K 2 0001168460-02-000052 000-32141 02805167 72160
2002-10-31 8-K 8K 6 0001168460-02-000051 000-32141 02803707 14028
2002-10-31 8-K/A AMENDMENT 2 0001168460-02-000050 000-32141 02803703 74511
2002-10-30 3 FORM 3 0001168460-02-000047 000-32141 02803581 12151
2002-09-09 8-K 8-K 2,7 0001086715-02-000079 000-32141 02758971 74277
2002-08-14 10-Q 630 10Q 0001168460-02-000043 000-32141 02733992 28271
2002-08-13 8-K 8-K 5,6,7 0001086715-02-000067 000-32141 02729998 15720
2002-05-14 10-Q 10-Q 0001086715-02-000036 000-32141 02644600 19889
2002-04-02 10KSB 10K 0001168460-02-000027 000-32141 02599025 84505
2002-04-01 NT 10-K EXTENSION FORM 0001168460-02-000026 000-32141 02598551 8758
2002-03-19 SC 13D 13D 0001168460-02-000011 005-62377 02578726 10852
2002-03-19 3 FORM 3 SORAM 0001168460-02-000010 000-32141 02578724 11975
2002-03-08 3 FORM 3 0001168460-02-000003 000-32141 02570285 11937
2002-02-28 8-K 8K 228 2,5 0001086715-02-000031 000-32141 02562022 39289
2001-12-26 SC 13D SC 13D 0001086715-01-500186 005-62377 1822797 10757
2001-12-26 SC 13D SC 13D 0001086715-01-500185 005-62377 1822765 10705
2001-12-26 SC 13D SC 13D 0001086715-01-500184 005-62377 1822685 10739
2001-12-26 8-K 8-K 1,2,5,6,7 0001086715-01-500182 000-32141 1822415 132250
2001-10-25 DEFS14A DEFINITIVE PROXY STATEMENT 0001086715-01-500152 000-32141 1765664 20300
2001-10-18 10-Q 10-K 0001086715-01-500140 000-32141 1761397 15286
2001-10-17 DEF 14A NUTRAPHARMA 14-A 0001086715-01-500137 000-32141 1760946 20202
2001-08-07 10-Q 10-Q 0001086715-01-500090 000-32141 1699782 15591
2001-05-16 10-Q 10-Q 0001086715-01-500027 000-32141 1640806 16713
2001-04-06 SB-2/A SB-2/A AND PROSPECTUS 0001086715-01-000094 333-44398 1597301 165387
2001-03-28 SB-2/A SB-2/A AND PROSPECTUS 0001086715-01-000081 333-44398 1582601 165797
2001-03-14 SB-2/A SB-2/A AND PROSPECTUS 0001086715-01-000065 333-44398 1568047 164338
2001-03-01 SB-2/A SB-2/A AND PROSPECTUS 0001086715-01-000053 333-44398 1558499 169897
2000-12-19 8-A12G 8-A 0001086715-00-000028 000-32141 791607 4906
2000-11-13 SB-2/A SB-2/A AND PROSPECTUS 0001086715-00-500012 333-44398 768039 166416
2000-10-05 SB-2/A SB-2/A AND PROSPECTUS 0001086715-00-000006 333-44398 735444 166214
2000-10-03 SB-2/A SB-2/A AND PROSPECTUS 0001119643-00-000002 333-44398 733747 164105
2000-08-24 SB-2 SB-2 AND PROSPECTUS 0001119643-00-000001 333-44398 708714 125574

Latest XBRL company facts

One latest value per concept from companyfacts (534 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 7.16B 2026-08-19 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
dei EntityPublicFloat Entity Public Float USD 702,697 2025-06-30 2025 FY 10-K 2026-05-20 0001493152-26-024641
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 0.1 2016-03-01 2016-03-31 2016 Q2 10-Q 2016-08-22 0001398432-16-000724
us-gaap AcceleratedShareRepurchaseProgramAdjustment Accelerated Share Repurchase Program, Adjustment USD 33.23M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 4,163 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent Accounts Payable and Accrued Liabilities USD 401,735 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 889,624 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 23,149 2024-09-30 2024 Q3 10-Q 2026-01-02 0001493152-26-000067
us-gaap AccrualForTaxesOtherThanIncomeTaxesCurrent Accrual for Taxes Other than Income Taxes, Current USD 1.09M 2015-12-31 2015 FY 10-K 2016-04-14 0001398432-16-000597
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 380,680 2015-08-17 2015 Q2 10-Q 2015-08-18 0001398432-15-000317
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 2.31M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 19,150 2022-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap AccruedLiabilitiesForCommissionsExpenseAndTaxes Accrued Liabilities for Commissions, Expense and Taxes USD 142,500 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 301,153 2026-03-31 2026 Q1 10-Q 2026-05-29 0001493152-26-026420
us-gaap AccruedPayrollTaxesCurrentAndNoncurrent Accrued Payroll Taxes USD 144,093 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 355,400 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AccruedProfessionalFeesCurrentAndNoncurrent Accrued Professional Fees USD 158,850 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 2.03M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AccruedSalariesCurrentAndNoncurrent Accrued Salaries USD 155,267 2015-12-31 2015 FY 10-K 2016-04-14 0001398432-16-000597
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 63,115 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1 Accumulated Depreciation, Depletion and Amortization, Sale or Disposal of Property, Plant and Equipment USD 2,210 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap AcquisitionCosts Acquisition Costs, Period Cost USD 2,611 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 52.57M 2021-03-31 2021 Q1 10-Q 2021-09-17 0001493152-21-022993
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 53.79M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 249,113 2018-01-01 2018-12-31 2019 FY 10-K 2021-07-01 0001493152-21-015860
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 42,325 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 1.47M 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 15,517 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap AdvancesFairValueDisclosure Advances, Fair Value Disclosure USD 45,000 2023-09-30 2023 Q3 10-Q 2025-10-28 0001493152-25-019875
us-gaap AdvancesOnInventoryPurchases Advances on Inventory Purchases USD 406,472 2025-12-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AdvertisingExpense Advertising Expense USD 2,765 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap AdvertisingRevenueCost Advertising Revenue Cost (Deprecated 2018-01-31) USD 500 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 7,500 2019-07-01 2019-09-30 2019 Q3 10-Q 2021-05-14 0001493152-21-011455
us-gaap AllocatedShareBasedCompensationExpenseNetOfTax Share-based Payment Arrangement, Expense, after Tax USD 36,329 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-18 0001398432-15-000317
us-gaap AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables Allowance for Doubtful Accounts, Premiums and Other Receivables USD 505,470 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2012-12-31 2012 FY 10-K 2013-04-16 0001144204-13-022247
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 2,789 2019-01-01 2019-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 132,175 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 14,635 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 32.66B 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap Assets Assets USD 622,863 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap AssetsCurrent Assets, Current USD 463,119 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap BankOverdrafts Bank Overdrafts USD 8,183 2013-06-30 2013 Q2 10-Q 2013-08-19 0001144204-13-046848
us-gaap Cash Cash USD 20,000 2026-01-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 12,181 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -3,634 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 12,181 2025-12-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -12,181 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap CashPeriodIncreaseDecrease Cash, Period Increase (Decrease) USD -31,243 2017-01-01 2017-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1 Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments USD 65,039 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.002 2023-03-31 2023 Q1 10-Q 2025-10-16 0001493152-25-018328
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 100,000 2014-04-30 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.00M 2017-04-30 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 36.30M 2020-10-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap ClassOfWarrantOrRightUnissued Class of Warrant or Right, Unissued shares 916,667 2016-03-31 2016 Q2 10-Q 2016-08-22 0001398432-16-000724
us-gaap CommitmentsAndContingencies Commitments and Contingencies USD 0 2013-09-30 2013 Q3 10-Q 2013-11-19 0001144204-13-063102
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 12.00B 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 7.16B 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 7.16B 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap CommonStockValue Common Stock, Value, Issued USD 7.16M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 0.27 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 233,331 2023-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 130,596 2018-01-01 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 16,040 2017-10-01 2017-10-31 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD -633,076 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 86.05M 2017-10-10 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap ConvertibleDebt Convertible Debt USD 37,450 2024-06-30 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap ConvertibleDebtFairValueDisclosures Convertible Debt, Fair Value Disclosures USD 4.50M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap ConvertibleDebtNoncurrent Convertible Debt, Noncurrent USD 1,820 2022-12-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 369,401 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010035
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 50,504 2023-06-30 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 1.16M 2018-12-31 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 615,230 2017-04-30 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap CostDirectMaterial Cost, Direct Material USD 41,268 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010035
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 54,536 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap CostOfRevenue Cost of Revenue USD 240,557 2024-01-01 2024-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap CostsAndExpenses Costs and Expenses USD 120,000 2022-01-01 2022-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap CostsAndExpensesRelatedParty Costs and Expenses, Related Party USD 161,500 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap CumulativeEarningsDeficit Cumulative Earnings (Deficit) USD -5.32M 2018-09-30 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 793,340 2018-01-01 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 164,145 2018-01-01 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 36,000 2022-02-06 2022-02-07 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 12.00M 2022-02-06 2022-02-07 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 110.00M 2015-02-27 2015-02-28 2019 Q3 10-Q 2021-05-14 0001493152-21-011455
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 110,000 2019-01-30 2019-01-31 2019 Q3 10-Q 2021-05-14 0001493152-21-011455
us-gaap DebtCurrent Debt, Current USD 8.49M 2024-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap DebtDefaultLongtermDebtAmount Debt Instrument, Debt Default, Amount USD 200,312 2024-02-29 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 3,450 2024-06-30 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 249,113 2018-01-01 2018-12-31 2019 FY 10-K 2021-07-01 0001493152-21-015860
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 0.005 2025-05-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap DebtInstrumentConvertibleConversionPriceDecrease Debt Instrument, Convertible, Conversion Price, Decrease USD/shares 0 2026-01-01 2026-01-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger pure 0.55 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-21 0001398432-18-000069
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 53,230 2024-06-30 2025 Q2 10-Q 2026-03-25 0001493152-26-012625
us-gaap DebtInstrumentFairValue Debt Instrument, Fair Value Disclosure USD 1,700 2018-04-30 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 62,795 2022-01-01 2022-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.08 2018-09-30 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap DebtInstrumentInterestRateEffectivePercentageRateRangeMaximum Debt Instrument, Interest Rate, Effective Percentage Rate Range, Maximum (Deprecated 2016-01-31) pure 0.2 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap DebtInstrumentInterestRateEffectivePercentageRateRangeMinimum Debt Instrument, Interest Rate, Effective Percentage Rate Range, Minimum (Deprecated 2016-01-31) pure 0.08 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.08 2012-12-31 2012 FY 10-K 2013-04-16 0001144204-13-022247
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 5,000 2026-01-01 2026-01-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal USD 5,000 2026-04-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 3,750 2025-05-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap DebtInstrumentUnamortizedDiscountCurrent Debt Instrument, Unamortized Discount, Current USD 17,814 2023-12-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap DebtInstrumentUnamortizedDiscountNoncurrent Debt Instrument, Unamortized Discount, Noncurrent USD 7,985 2024-12-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD 17,870 2018-12-31 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap DebtInstrumentUnamortizedDiscountPremiumNet Debt Instrument, Unamortized Discount (Premium), Net USD 4.95M 2023-12-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap DebtInstrumentUnamortizedPremium Debt Instrument, Unamortized Premium USD 1,831 2023-06-30 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap DebtIssuanceCosts Debt Issuance Cost (Deprecated 2016-01-31) USD 2,714 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-19 0001398432-15-000257
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 129,466 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001398432-16-000597
us-gaap DebtLongtermAndShorttermCombinedAmount Debt, Long-term and Short-term, Combined Amount USD 92,310 2014-06-30 2014 Q2 10-Q 2014-08-14 0001398432-14-000313
us-gaap DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1 Debtor Reorganization Items, Gain (Loss) on Settlement of Other Claims, Net USD -20,423 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap DeferredCompensationArrangementWithIndividualCompensationExpense Deferred Compensation Arrangement with Individual, Compensation Expense USD 544,000 2011-01-01 2011-09-30 2011 Q3 10-Q 2011-11-15 0001144204-11-064907
us-gaap DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued Deferred Compensation Arrangement with Individual, Fair Value of Shares Issued USD 0 2012-01-01 2012-09-30 2012 Q3 10-Q/A 2012-12-12 0001144204-12-067558
us-gaap DeferredCompensationArrangementWithIndividualRecordedLiability Deferred Compensation Arrangement with Individual, Recorded Liability USD 10,000 2022-09-30 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap DeferredCompensationEquity Deferred Compensation Equity USD 20,500 2021-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 1.87M 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001398432-16-000597
us-gaap DeferredRentCredit Deferred Rent Credit USD 126,339 2015-12-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap DeferredRevenue Deferred Revenue USD 234,757 2024-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 111,011 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033171
us-gaap DeferredRevenuePeriodIncreaseDecrease Deferred Revenue, Period Increase (Decrease) USD 2,780 2018-01-01 2018-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap DeferredTaxAssetsGrossCurrent Deferred Tax Assets, Gross, Current USD 155,267 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 40,631 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap DeferredTaxAssetsNetCurrent Deferred Tax Assets, Net of Valuation Allowance, Current USD 0 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap DeferredTaxAssetsNetNoncurrent Deferred Tax Assets, Net of Valuation Allowance, Noncurrent USD 0 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 8.62M 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 470,100 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation USD 101,877 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals USD 296,834 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Allowance for Doubtful Accounts USD 13,382 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 14,954 2019-12-31 2019 FY 10-K 2021-07-01 0001493152-21-015860
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 9.19M 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap DeferredTaxAssetsValuationAllowanceCurrent Deferred Tax Assets, Valuation Allowance, Current USD -347,674 2017-12-31 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap DeferredTaxAssetsValuationAllowanceNoncurrent Deferred Tax Assets, Valuation Allowance, Noncurrent USD 9.39M 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap DefinedBenefitPlanAssetsTransferredToFromPlan Defined Benefit Plan, Plan Assets, Increase (Decrease) for Assets Transferred to (from) Plan USD 250,420 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap DefinedBenefitPlanFairValueOfPlanAssets Defined Benefit Plan, Plan Assets, Amount USD 1.29M 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap DefinedBenefitPlanFairValueOfPlanAssetsPeriodIncreaseDecrease Defined Benefit Plan, Plan Assets, Period Increase (Decrease) USD 485,525 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap DefinedBenefitPlanGrossPrescriptionDrugSubsidyReceiptsReceived Defined Benefit Plan, Gross Prescription Drug Subsidy Receipts Received (Deprecated 2017-01-31) USD 63,696 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap DefinedBenefitPlanPurchasesSalesAndSettlements Defined Benefit Plan, Plan Assets Level 3 Reconciliation, Increase (Decrease) for Purchase, Sale, and Settlement USD 160,870 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1 Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Gain (Loss) Due to Settlement USD 26,810 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap DefinedBenefitPlanSettlementsBenefitObligation Defined Benefit Plan, Benefit Obligation, (Increase) Decrease for Settlement USD 315,000 2015-01-01 2015-12-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap DepositLiabilitiesAccruedInterest Deposit Liabilities, Accrued Interest USD 150,372 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap Depreciation Depreciation USD 4,859 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 9,084 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010035
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 4,858 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap DepreciationExpenseOnReclassifiedAssets Depreciation Expense on Reclassified Assets USD 6,421 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-22 0001398432-16-000772
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 62,424 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 2.04M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD 1.40M 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 2.04M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap DerivativeLossOnDerivative Derivative, Loss on Derivative USD 1.40M 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap DilutiveSecuritiesEffectOnBasicEarningsPerShareOther Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities USD -2.58M 2020-01-01 2020-09-30 2020 Q3 10-Q 2021-08-12 0001493152-21-019469
us-gaap DueFromOfficersOrStockholders Due from Officers or Stockholders USD 269,772 2017-12-31 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap DueFromOtherRelatedParties Due from Other Related Parties USD 84,507 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 269,772 2017-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 61,439 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033171
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 41,328 2016-09-30 2016 Q3 10-Q 2016-11-22 0001398432-16-000772
us-gaap EarlyRepaymentOfSubordinatedDebt Early Repayment of Subordinated Debt USD 54,663 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-19 0001398432-15-000257
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010035
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.254 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.012 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.055 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 21,205 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-19 0001398432-15-000257
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 680,235 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 10,575 2022-01-01 2022-12-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 16,000 2019-09-30 2019 Q3 10-Q 2021-05-14 0001493152-21-011455
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount USD 3,333 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 8,500 2019-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap ExtinguishmentOfDebtAmount Extinguishment of Debt, Amount USD 100,000 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-22 0001398432-16-000724
us-gaap ExtinguishmentOfDebtGainLossNetOfTax Extinguishment of Debt, Gain (Loss), Net of Tax USD 728,223 2018-01-01 2018-09-30 2019 Q3 10-Q 2021-05-14 0001493152-21-011455
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 16,500 2020-10-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap FairValueAssumptionsExercisePrice Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) USD 0 2015-09-30 2015 Q3 10-Q 2015-11-23 0001398432-15-000411
us-gaap FairValueAssumptionsExpectedDividendPayments Fair Value Assumptions, Expected Dividend Payments (Deprecated 2018-01-31) USD 0 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-19 0001398432-15-000257
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 2.043 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-22 0001398432-16-000772
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings USD 466 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchasesSalesIssuancesSettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases, (Sales), Issuances, (Settlements) USD 948,052 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales USD 24,017 2017-01-01 2017-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value USD 1,934 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisInstrumentsClassifiedInShareholdersEquityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Instruments Classified in Shareholders' Equity, Gain (Loss) Included in Earnings (Deprecated 2019-01-31) USD -3,928 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 610,482 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033171
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD 2.45M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) USD 324,379 2022-01-01 2022-12-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 4.50M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap FairValueOfAssetsAcquired Fair Value of Assets Acquired USD 122,364 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-19 0001398432-15-000257
us-gaap FederalHomeLoanBankAdvancesInterestRate Federal Home Loan Bank, Advances, Interest Rate pure 0.04 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap FeesAndCommissionsDepositorAccounts Fees and Commissions, Depositor Accounts (Deprecated 2018-01-31) USD 35,296 2015-07-02 2015-07-18 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 132,939 2022-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 7.93M 2022-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 3,707 2022-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 3,571 2022-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 3,440 2022-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 110,773 2022-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap FinancialInstrumentsOwnedAtFairValue Financial Instruments, Owned, at Fair Value USD 1.67M 2016-12-31 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap FinancialInstrumentsOwnedCorporateEquitiesAtFairValue Financial Instruments, Owned, Corporate Equities, at Fair Value USD 25.12M 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2012-12-31 2012 FY 10-K 2013-04-16 0001144204-13-022247
us-gaap FinancingReceivableAllowanceForCreditLossesRecovery Financing Receivable, Allowance for Credit Loss, Recovery USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-16 0001144204-13-022247
us-gaap FinancingReceivableAllowanceForCreditLossesWriteOffs Financing Receivable, Allowance for Credit Loss, Writeoff USD 603,893 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-16 0001144204-13-022247
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 51,545 2014-01-01 2014-03-31 2014 Q1 10-Q 2014-05-20 0001552781-14-000479
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD 22,577 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-11-15 0001144204-12-063254
us-gaap GainLossOnSaleOfNotesReceivable Gain (Loss) on Sale of Financing Receivable USD 1.24M 2016-01-01 2016-12-31 2016 FY 10-K 2017-04-17 0001398432-17-000073
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 39,667 2023-01-01 2023-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 200,000 2019-01-01 2019-12-31 2019 FY 10-K 2021-07-01 0001493152-21-015860
us-gaap GainOnDerivativeInstrumentsPretax Gain on Derivative Instruments, Pretax USD 667,795 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 140,500 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 0 2011-12-31 2011 FY 10-K/A 2012-11-15 0001144204-12-063254
us-gaap GrossProfit Gross Profit USD 51,600 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -4.41M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2018-01-01 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap IncomeTaxExaminationInterestAccrued Income Tax Examination, Interest Accrued USD 157,128 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap IncomeTaxExaminationPenaltiesExpense Income Tax Examination, Penalties Expense USD 35,296 2015-07-18 2016 FY 10-K 2017-04-17 0001398432-17-000073
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-16 0001144204-13-022247
us-gaap IncomeTaxExpenseBenefitIntraperiodTaxAllocation Income Tax Expense (Benefit), Intraperiod Tax Allocation USD 207,730 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001398432-16-000597
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -443,284 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 4.13M 2018-01-01 2018-12-31 2019 FY 10-K 2021-07-01 0001493152-21-015860
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -429,952 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 558,448 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 65,205 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -88,959 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD -27,173 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 61,215 2024-01-01 2024-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 102,900 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 8,564 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 36,043 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 394 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncreaseDecreaseInAccountsReceivableRelatedParties Increase (Decrease) in Accounts Receivable, Related Parties USD -2,818 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 115,811 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap IncreaseDecreaseInAccruedSalaries Increase (Decrease) in Accrued Salaries USD 135,048 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncreaseDecreaseInBookOverdrafts Increase (Decrease) in Book Overdrafts USD 8,183 2013-01-01 2013-06-30 2014 Q2 10-Q 2014-08-14 0001398432-14-000313
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 51,094 2024-01-01 2024-09-30 2024 Q3 10-Q 2026-01-02 0001493152-26-000067
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 51,094 2024-01-01 2024-09-30 2025 Q3 10-Q 2026-04-06 0001493152-26-015334
us-gaap IncreaseDecreaseInDueFromEmployeeCurrent Increase (Decrease) in Due from Employee, Current USD 9,511 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncreaseDecreaseInDueFromRelatedPartiesCurrent Increase (Decrease) in Due from Related Parties, Current USD -1,028 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-29 0001493152-26-026420
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 9,584 2025-01-01 2025-06-30 2025 Q2 10-Q 2026-03-25 0001493152-26-012625
us-gaap IncreaseDecreaseInFinanceReceivables Increase (Decrease) in Finance Receivables USD 3,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 12,250 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -3,952 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncreaseDecreaseInNotesPayableCurrent Increase (Decrease) in Notes Payable, Current USD 100,000 2019-05-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -45,774 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 127,853 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 2,472 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-19 0001144204-13-063102
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD 29,288 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD -30,990 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap IncreaseDecreaseInOtherReceivables Increase (Decrease) in Other Receivables USD 100,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 16,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 610.99M 2022-01-01 2022-06-30 2023 Q2 10-Q 2025-10-23 0001493152-25-019037
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 11.59B 2022-01-01 2022-12-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap InducedConversionOfConvertibleDebtExpense Induced Conversion of Convertible Debt Expense USD -1.02M 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-22 0001398432-16-000772
us-gaap IntercompanyForeignCurrencyBalanceAmount Intercompany Foreign Currency Balance, Amount USD -172,260 2015-09-30 2015 Q3 10-Q 2015-11-23 0001398432-15-000411
us-gaap InterestAndDividendsPayableCurrent Interest and Dividends Payable, Current USD 967,856 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InterestExpense Interest Expense USD 12,250 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InterestExpenseDebt Interest Expense, Debt USD 198,282 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InterestExpenseOther Interest Expense, Other USD 2,812 2024-01-01 2024-06-30 2024 Q2 10-Q 2025-12-23 0001493152-25-028946
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 12,740 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033171
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 3,536 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap InterestOnConvertibleDebtNetOfTax Interest on Convertible Debt, Net of Tax USD 53,084 2025-04-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 5,425 2018-01-01 2018-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 3,816 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InterestPayableCurrent Interest Payable, Current USD 215,081 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 21,023 2018-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010035
us-gaap InventoryAdjustments Inventory Adjustments USD 401,472 2024-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 11,509 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 2,095 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap InventoryGross Inventory, Gross USD 114,753 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InventoryLIFOReserve Inventory, LIFO Reserve USD 30,885 2018-09-30 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap InventoryNet Inventory, Net USD 23,509 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InventoryNoncurrent Inventory, Noncurrent USD 91,244 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 103,244 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InventoryRawMaterialsAndSuppliesNetOfReserves Inventory, Raw Materials and Supplies, Net of Reserves USD 5,000 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap InventoryValuationReserves Inventory Valuation Reserves USD 406,472 2025-12-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 15,591 2018-06-30 2018 Q2 10-Q 2018-08-17 0001398432-18-000103
us-gaap InventoryWriteDown Inventory Write-down USD 405,404 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 8,147 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap LaborAndRelatedExpense Labor and Related Expense USD 355,031 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 128,897 2018-01-01 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap LeaseCost Lease, Cost USD 103,080 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 121,220 2024-09-30 2024 Q3 10-Q 2026-01-02 0001493152-26-000067
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 97,508 2024-09-30 2024 Q3 10-Q 2026-01-02 0001493152-26-000067
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 97,508 2022-12-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 97,508 2023-12-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 23,712 2024-09-30 2024 Q3 10-Q 2026-01-02 0001493152-26-000067
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 6,253 2024-09-30 2024 Q3 10-Q 2026-01-02 0001493152-26-000067
us-gaap Liabilities Liabilities USD 21.83M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 622,863 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LiabilitiesCurrent Liabilities, Current USD 21.70M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 8.50M 2019-09-30 2019 Q3 10-Q 2021-05-14 0001493152-21-011455
us-gaap LineOfCreditFacilityIncreaseAccruedInterest Line of Credit Facility, Increase, Accrued Interest USD 32,676 2020-01-01 2020-06-30 2020 Q2 10-Q 2021-08-05 0001493152-21-018715
us-gaap LineOfCreditFacilityMaximumMonthendOutstandingAmount Line of Credit Facility, Maximum Month-end Outstanding Amount USD 35,508 2019-02-01 2019-02-28 2019 Q1 10-Q 2021-04-05 0001398432-21-000029
us-gaap LitigationReserve Estimated Litigation Liability USD 39,020 2016-12-31 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap LoanPortfolioExpense Loan Portfolio Expense USD 9,901 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap LoanProcessingFee Loan Processing Fee USD -7,500 2015-01-01 2015-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap LongTermDebt Long-term Debt USD 12.57M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LongTermDebtAndCapitalLeaseObligationsCurrent Long-term Debt and Lease Obligation, Current USD 68,806 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 12.44M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 125,094 2024-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD 12.44M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 8.49M 2024-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five USD 118,812 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive Long-term Debt, Maturities, Repayments of Principal in Rolling Year Five USD 4,226 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour Long-term Debt, Maturities, Repayments of Principal in Rolling Year Four USD 4,071 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three USD 3,922 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two USD 3,777 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 3,996 2024-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 3,849 2024-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 3,707 2024-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 3,571 2024-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 8.29M 2024-09-30 2024 Q3 10-Q 2026-01-02 0001493152-26-000067
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 134,808 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 134,808 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap LossContingencyAccrualProvision Loss Contingency Accrual, Provision USD 200,000 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-22 0001398432-16-000724
us-gaap LossOnDerivativeInstrumentsPretax Loss on Derivative Instruments, Pretax USD 143,075 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-19 0001144204-13-063102
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 566,833 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 528,118 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -51,052 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 0 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -579,014 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -265,734 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -4.41M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap NetIncomeLossAttributableToParentDiluted Net Income (Loss) Attributable to Parent, Diluted USD -1.39M 2023-01-01 2023-12-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -3.95M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -3.95M 2026-04-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap NonoperatingGainsLosses Nonoperating Gains (Losses) USD 750 2022-08-01 2022-08-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -3.59M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap NotesAndLoansReceivableNetCurrent Financing Receivable, after Allowance for Credit Loss, Current USD 270,896 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033171
us-gaap NotesIssued1 Notes Issued USD 276,752 2022-01-01 2022-12-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap NotesPayable Notes Payable USD 172,500 2026-01-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap NotesPayableCurrent Notes Payable, Current USD 14,361 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 35,000 2015-12-31 2016 Q2 10-Q 2016-08-22 0001398432-16-000724
us-gaap NotesPayableRelatedPartiesCurrentAndNoncurrent Notes Payable, Related Parties USD 14,400 2019-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 4,707 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033171
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-29 0001493152-26-026420
us-gaap OperatingCostsAndExpenses Operating Costs and Expenses USD 608,922 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap OperatingExpenses Operating Expenses USD 866,313 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -814,713 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap OperatingLeaseCost Operating Lease, Cost USD 103,080 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 93,411 2024-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 93,411 2024-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 93,411 2023-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap OperatingLeasePayments Operating Lease, Payments USD 73,494 2023-01-01 2023-09-30 2023 Q3 10-Q 2025-10-28 0001493152-25-019875
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 90,783 2024-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 44,462 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 284,685 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 86,345 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 54,490 2018-09-30 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 15,567 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 93,122 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 89,651 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap OperatingLeasesFutureMinimumPaymentsReceivable Operating Leases, Future Minimum Payments Receivable USD 483,086 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableCurrent Operating Leases, Future Minimum Payments Receivable, Current USD 30,819 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears Operating Leases, Future Minimum Payments Receivable, in Five Years USD 91,379 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInFourYears Operating Leases, Future Minimum Payments Receivable, in Four Years USD 87,991 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears Operating Leases, Future Minimum Payments Receivable, in Three Years USD 91,913 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears Operating Leases, Future Minimum Payments Receivable, in Two Years USD 126,494 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap OperatingLeasesFutureMinimumPaymentsReceivableThereafter Operating Leases, Future Minimum Payments Receivable, Thereafter USD 54,490 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.08 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 34.00M 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 32.27M 2015-12-31 2015 FY 10-K 2016-04-14 0001398432-16-000597
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 2,913 2026-03-31 2026 Q1 10-Q 2026-05-29 0001493152-26-026420
us-gaap OtherAccruedLiabilitiesCurrentAndNoncurrent Other Accrued Liabilities USD 18,833 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 15,550 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap OtherExpenses Other Expenses USD 500 2022-08-01 2022-08-31 2022 Q3 10-Q 2022-11-21 0001493152-22-033171
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 54,700 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap OtherIncome Other Income USD 5,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.77M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap OtherLoansPayableCurrent Other Loans Payable, Current USD 4.87M 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap OtherLongTermDebt Other Long-term Debt USD 10,443 2014-09-30 2014 Q3 10-Q 2014-11-14 0001398432-14-000409
us-gaap OtherLongTermDebtCurrent Other Long-term Debt, Current USD 9.61M 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap OtherLongTermNotesPayable Other Notes Payable, Noncurrent USD 51,410 2018-12-31 2019 FY 10-K 2021-07-01 0001493152-21-015860
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -24,373 2013-01-01 2013-09-30 2013 Q3 10-Q 2013-11-19 0001144204-13-063102
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 2,305 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 5,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-09-08 0001493152-21-022204
us-gaap OtherNotesPayable Other Notes Payable USD 8.46M 2024-06-30 2024 Q2 10-Q 2025-12-23 0001493152-25-028946
us-gaap OtherNotesPayableCurrent Other Notes Payable, Current USD 746,285 2016-03-31 2016 Q2 10-Q 2016-08-22 0001398432-16-000724
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 150,999 2025-03-31 2025 Q1 10-Q 2026-03-11 0001493152-26-009667
us-gaap OtherReceivables Other Receivables USD 133,906 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 133,906 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap OtherSellingAndMarketingExpense Other Selling and Marketing Expense USD 1.20M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap OtherTaxExpenseBenefit Other Tax Expense (Benefit) USD -1.78M 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001398432-16-000597
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 1,159 2013-01-01 2013-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap PaymentsForCommissions Payments for Commissions USD 45,500 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001398432-17-000126
us-gaap PaymentsForLegalSettlements Payments for Legal Settlements USD 680,235 2025-01-01 2025-09-30 2025 Q3 10-Q 2026-04-06 0001493152-26-015334
us-gaap PaymentsForOtherOperatingActivities Payments for Other Operating Activities USD 584,861 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001398432-17-000126
us-gaap PaymentsForPostemploymentBenefits Payments for Postemployment Benefits USD 69,565 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001398432-17-000126
us-gaap PaymentsForProceedsFromPolicyLoans Payments for (Proceeds from) Policy Loans USD 4,800 2015-07-01 2015-08-17 2015 Q2 10-Q 2015-08-18 0001398432-15-000317
us-gaap PaymentsForRent Payments for Rent USD 5,000 2022-05-01 2022-05-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap PaymentsToAcquireNotesReceivable Payments to Acquire Notes Receivable USD 25,000 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 26,052 2025-01-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap PaymentsToSuppliers Payments to Suppliers USD 26,785 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001398432-17-000126
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap PreferredStockPerShareAmountsOfPreferredDividendsInArrears Preferred Stock, Per Share Amounts of Preferred Dividends in Arrears USD/shares 3.00M 2017-10-30 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 12,000 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap PrepaidAdvertising Prepaid Advertising USD 30,000 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 49,499 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 49,499 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap PrepaidExpenseOtherNoncurrent Prepaid Expense Other, Noncurrent USD 13,000 2018-03-31 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 463,001 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap ProceedsFromCustomers Proceeds from Customers USD 95,589 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001398432-17-000126
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 55,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap ProceedsFromIssuanceOfOtherLongTermDebt Proceeds from Issuance of Other Long-term Debt USD 112,650 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 83,250 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap ProceedsFromOtherDebt Proceeds from Other Debt USD 896,750 2016-01-01 2016-12-31 2016 FY 10-K 2017-04-17 0001398432-17-000073
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 254,057 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap ProceedsFromRepaymentsOfDebt Proceeds from (Repayments of) Debt USD 101,750 2022-10-01 2022-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 42,300 2024-01-01 2024-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap ProceedsFromRepaymentsOfRestrictedCashFinancingActivities Proceeds from (Repayments of) Restricted Cash, Financing Activities USD -189,319 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap ProceedsFromSaleOfEquitySecuritiesFvNi ProceedsFromSaleOfEquitySecuritiesFvNi USD 33,516 2023-01-01 2023-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap ProceedsFromSaleOfNotesReceivable Proceeds from Sale of Notes Receivable USD 42,300 2024-01-01 2024-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 83,649 2023-01-01 2023-12-31 2024 FY 10-K 2026-02-17 0001493152-26-007044
us-gaap ProceedsFromSecuredNotesPayable Proceeds from Secured Notes Payable USD 200,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap ProceedsFromShortTermDebt Proceeds from Short-term Debt USD 134,151 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-22 0001398432-16-000724
us-gaap ProductWarrantyAccrualClassifiedCurrent Product Warranty Accrual, Current USD 1,934 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ProfessionalFees Professional Fees USD 289,350 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -4.03M 2017-01-01 2017-12-31 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 84,061 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 20,946 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap PropertyPlantAndEquipmentOtherAccumulatedDepreciation Property, Plant and Equipment, Other, Accumulated Depreciation USD 1,105 2019-03-31 2019 Q1 10-Q 2021-04-05 0001398432-21-000029
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 52,800 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap ProvisionForLoanLeaseAndOtherLosses Provision for Loan, Lease, and Other Losses USD 0 2012-01-01 2012-12-31 2012 FY 10-K 2013-04-16 0001144204-13-022247
us-gaap ProvisionForOtherCreditLosses Provision for Other Credit Losses USD 52,800 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 5,000 2025-04-01 2025-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap RelatedPartyTransactionPurchasesFromRelatedParty Related Party Transaction, Purchases from Related Party USD 37,416 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 80,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001398432-16-000597
us-gaap RentalIncomeNonoperating Rental Income, Nonoperating USD 9,000 2020-01-01 2020-09-30 2020 Q3 10-Q 2021-08-12 0001493152-21-019469
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 37,825 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap RepaymentsOfDebt Repayments of Debt USD 5,000 2023-03-01 2023-03-31 2024 Q2 10-Q 2025-12-23 0001493152-25-028946
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 122,650 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 15,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-29 0001493152-26-026420
us-gaap RepaymentsOfOtherLongTermDebt Repayments of Other Long-term Debt USD 287,072 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 73,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 85,905 2016-01-01 2016-06-30 2016 Q2 10-Q 2016-08-22 0001398432-16-000724
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 0 2013-01-01 2013-03-31 2013 Q1 10-Q 2013-05-20 0001144204-13-030545
us-gaap RestrictedInvestmentsAtFairValue Restricted Investments, at Fair Value USD 26,048 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap RestrictedInvestmentsNotExemptFromRegistrationAtFairValue Restricted Investments Not Exempt from Registration, at Fair Value (Deprecated 2020-01-31) USD 12,000 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 324,552 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -82.69M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 61,709 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 0 2011-01-01 2011-12-31 2011 FY 10-K/A 2012-11-15 0001144204-12-063254
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 154,966 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-21 0001493152-22-033171
us-gaap Revenues Revenues USD 51,537 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability Right-of-Use Asset Obtained in Exchange for Finance Lease Liability USD 281,175 2018-01-01 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap SalesReturnsAndAllowancesGoods Sales Returns and Allowances, Goods (Deprecated 2018-01-31) USD 503,958 2011-01-01 2011-12-31 2013 Q2 10-Q 2013-08-19 0001144204-13-046848
us-gaap SalesRevenueGoodsGross Sales Revenue, Goods, Gross (Deprecated 2018-01-31) USD 95,589 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001398432-17-000126
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 50,158 2017-01-01 2017-06-30 2017 Q2 10-Q 2017-08-14 0001398432-17-000126
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 88,207 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap SecuredDebt Secured Debt USD 129,466 2014-12-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap SecuredDebtOther Secured Debt, Other USD 60,000 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap SecuredLongTermDebt Secured Long-term Debt, Noncurrent USD 105,640 2022-12-31 2023 FY 10-K 2025-11-24 0001493152-25-024800
us-gaap SecuritiesReceivedAsCollateral Securities Received as Collateral USD 60,161 2014-06-30 2014 Q2 10-Q 2014-08-14 0001398432-14-000313
us-gaap SecurityDeposit Security Deposit USD 8,803 2024-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 494,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001398432-14-000409
us-gaap SellingExpense Selling Expense USD 434,000 2014-01-01 2014-09-30 2014 Q3 10-Q 2014-11-14 0001398432-14-000409
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 1.20M 2025-01-01 2025-09-30 2025 Q3 10-Q 2026-04-06 0001493152-26-015334
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 307,732 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 14,833 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested USD 0 2019-03-31 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Intrinsic Value, Amount Per Share USD/shares 0.55 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 1.00M 2015-01-01 2015-12-31 2016 FY 10-K 2017-04-17 0001398432-17-000073
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOther Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Other shares 82.14M 2023-01-01 2023-03-31 2023 Q1 10-Q 2025-10-16 0001493152-25-018328
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.026 2018-09-30 2018 Q3 10-Q 2018-11-19 0001398432-18-000131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 4.10M 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 20.60M 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 3.42M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 118.50M 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 0 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price USD/shares 0.008 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 110.00M 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award shares 25.12M 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.35 2017-01-01 2017-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0.021 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.005 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit USD/shares 0.005 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit USD/shares 1 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-20 0001398432-17-000163
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionStockholdersEquity Share-based Goods and Nonemployee Services Transaction, Stockholders' Equity USD 50,000 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Dividend Rate pure 0 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate Share-based Goods and Nonemployee Services Transaction, Valuation Method, Expected Volatility Rate pure 2.56 2018-01-01 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap SharePrice Share Price USD/shares 0.133 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap SharesIssued Shares, Issued shares 12.50M 2021-10-31 2021 FY 10-K 2022-04-15 0001493152-22-010035
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.18 2015-07-31 2022 FY 10-K 2025-09-03 0001641172-25-026446
us-gaap ShortTermInvestments Short-term Investments USD 17,600 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 18,698 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010035
us-gaap StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants USD 33,440 2015-01-01 2015-12-31 2016 FY 10-K 2017-04-17 0001398432-17-000073
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 353,006 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-22 0001398432-16-000772
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD -21.21M 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap StockholdersEquityBeforeTreasuryStock Stockholders' Equity before Treasury Stock USD 3.59M 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD -23.62M 2021-09-30 2021 Q3 10-Q 2021-11-10 0001493152-21-027793
us-gaap StockIssued1 Stock Issued USD 12,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 5,895 2019-09-29 2019-09-30 2019 Q3 10-Q 2021-05-14 0001493152-21-011455
us-gaap StockIssuedDuringPeriodSharesConversionOfUnits Stock Issued During Period, Shares, Conversion of Units shares 400,000 2015-12-01 2015-12-31 2016 FY 10-K 2017-04-17 0001398432-17-000073
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 120.00M 2025-10-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 60.00M 2026-01-01 2026-01-31 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap StockIssuedDuringPeriodSharesOther Stock Issued During Period, Shares, Other shares 100.00M 2025-05-01 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited Stock Issued During Period, Shares, Restricted Stock Award, Forfeited shares 125,000 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross shares 25.00M 2021-01-01 2021-01-31 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 36.30M 2021-08-01 2021-08-31 2021 Q3 10-Q 2021-11-10 0001493152-21-027793
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 12,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 15,810 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001398432-16-000597
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 33,440 2015-12-01 2015-12-31 2016 FY 10-K 2017-04-17 0001398432-17-000073
us-gaap StockIssuedDuringPeriodValueDividendReinvestmentPlan Stock Issued During Period, Value, Dividend Reinvestment Plan USD 15,665 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 200,900 2016-01-01 2016-12-31 2017 FY 10-K 2018-04-17 0001398432-18-000049
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 324,552 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap StockIssuedDuringPeriodValueIssuedForCash Development Stage Entities, Stock Issued, Value, Issued for Cash (Deprecated 2015-01-31) USD 159,500 2011-01-01 2011-12-31 2012 FY 10-K 2013-04-16 0001144204-13-022247
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 20,000 2025-10-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 30,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 10,000 2025-05-01 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 13,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 60,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased shares 8.00B 2018-03-07 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap SubleaseIncome Sublease Income USD 120,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap Supplies Prepaid Supplies USD 100,946 2011-06-30 2011 Q2 10-Q 2011-08-15 0001144204-11-047222
us-gaap TaxAdjustmentsSettlementsAndUnusualProvisions Tax Adjustments, Settlements, and Unusual Provisions USD -304,273 2015-01-01 2015-12-31 2015 FY 10-K 2016-04-14 0001398432-16-000597
us-gaap TreasuryStockDeferredEmployeeStockOwnershipPlan Deferred Employee Stock Ownership Plan, Issuance of Shares or Sale of Treasury Shares USD 50,000 2018-12-31 2018 FY 10-K 2021-02-05 0001398432-21-000007
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD -111,980 2012-01-01 2012-03-31 2012 Q1 10-Q/A 2012-11-28 0001144204-12-065280
us-gaap UnrealizedGainLossOnHybridInstrumentNet Unrealized Gain (Loss) on Hybrid Instrument, Net USD 729,093 2013-01-01 2013-12-31 2013 FY 10-K 2014-03-31 0001144204-14-019555
us-gaap UnsecuredDebt Unsecured Debt USD 146,770 2015-12-31 2016 Q1 10-Q 2016-06-21 0001398432-16-000672
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 443,284 2025-01-01 2025-12-31 2025 FY 10-K 2026-05-20 0001493152-26-024641
us-gaap ValuationAllowancesAndReservesAdjustments SEC Schedule, 12-09, Valuation Allowances and Reserves, Increase (Decrease) Adjustment USD 155,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-04-13 0001398432-15-000168
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 0 2018-12-31 2019 Q3 10-Q 2021-05-14 0001493152-21-011455
us-gaap WeightedAverageNumberDilutedSharesOutstandingAdjustment Weighted Average Number Diluted Shares Outstanding Adjustment shares 7.60B 2023-01-01 2023-03-31 2023 Q1 10-Q 2025-10-16 0001493152-25-018328
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 8.04B 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 7.23B 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-15 0001493152-22-010035
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 0.001 2019-01-01 2019-06-30 2019 Q2 10-Q 2021-05-07 0001398432-21-000040
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 8.04B 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-19 0001493152-26-039166
us-gaap WeightedAverageNumberOfSharesRestrictedStock Weighted Average Number of Shares, Restricted Stock shares 1.25M 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-19 0001398432-15-000257

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →